Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+0.00%
trims when stocks drop
when a holding falls −10%+
Middle response
+0.00%
baseline attrition
Rally response
-15.90%
trims into rallies
when a holding rises +10%+
Top positions · 6
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| ACLXArcellx, Inc. | $26M | 84.1% | — | 2.3 yr |
| KYMRKymera Therapeutics, Inc | $2M | 5.4% | +204.3% | 3.5 yr |
| SEERSeer, Inc. | $2M | 5.1% | -0.6% | 3.5 yr |
| RLYBRallybio Corporation | $1M | 2.8% | — | 0.3 yr |
| STROSutro Biopharma, Inc. | $0M | 1.4% | +282.6% | 3.5 yr |
| XLOXilio Therapeutics, Inc. | $0M | 1.3% | — | 0.3 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+1.3pp$31M
Country
US100.0%+1.3pp
Top 5: 98.7% · Top 10: 100.0% · Top 25: 100.0%
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| SEER | $1M | -0.00B | -0.6% |
Top sells this quarter · 2
| — exit | −$0M |
| — exit | −$0M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31M | 6 | +188.63% | +17.59% | +171.03% | +0.01B |
| 2025-12-31 | $19M | 6 | +66.36% | +17.72% | +48.64% | -0.14B |
| 2025-09-30 | $115M | 7 | +12.23% | +17.52% | -5.28% | -0.00B |
| 2025-06-30 | $92M | 8 | -9.76% | +3.33% | -13.09% | -0.04B |
| 2025-03-31 | $84M | 8 | -69.67% | -21.75% | -47.93% | +0.02B |
| 2024-12-31 | $103M | 8 | -9.58% | +2.49% | -12.07% | +0.05B |
| 2022-09-30 | $58M | 7 | +2.19% | -4.93% | +7.12% | +0.01B |
| 2022-06-30 | $52M | 7 | -48.70% | -16.11% | -32.59% | +0.02B |
| 2022-03-31 | $65M | 7 | — | — | — | -0.01B |
| 2021-12-31 | $72M | 6 | — | — | — | -0.08B |
| 2021-09-30 | $155M | 11 | — | — | — | -0.02B |
| 2021-06-30 | $173M | 11 | — | — | — | -0.09B |
| 2021-03-31 | $265M | 11 | — | — | — | +0.00B |
| 2020-12-31 | $264M | 11 | — | — | — | — |